Rankings
▼
Calendar
MYGN FY 2024 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena
MYGN
Myriad Genetics, Inc.
$487M
FY 2024 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$838M
+11.2% YoY
Gross Profit
$585M
69.9% margin
Operating Income
-$124M
-14.7% margin
Net Income
-$127M
-15.2% margin
EPS (Diluted)
$-1.41
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$38M
Stock-Based Comp.
$50M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$327M
Stockholders' Equity
$701M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$838M
$753M
+11.2%
Gross Profit
$585M
$517M
+13.2%
Operating Income
-$124M
-$257M
+52.0%
Net Income
-$127M
-$263M
+51.7%
← Q4 2023
All Quarters
Q1 2024 →